NEW YORK, NY / ACCESSWIRE / April 14, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Infinity Q Diversified Alpha Fund Institutional Class (NASDAQ:IQDNX)
Class Period: December 21, 2018 - February 22, 2021
Lead Plaintiff Deadline: April 27, 2021
The IQDNX lawsuit alleges that Infinity Q Diversified Alpha Fund Institutional Class made materially false and/or misleading statements and/or failed to disclose that: (1) Infinity Q's Chief Investment Officer made adjustments to certain parameters within the third-party pricing model that affected the valuation of the swaps held by the Fund; (2) consequently, Infinity Q would not be able to calculate NAV correctly; (3) as a result, the previously reported NAVs were unreliable; (4) because of the foregoing, the Fund would halt redemptions and liquidate its assets; and (5) as a result, the Prospectuses were materially false and/or misleading and failed to state information required to be stated therein.
Learn about your recoverable losses in IQDNX: http://www.kleinstocklaw.com/pslra-1/infinity-q-diversified-alpha-fund-loss-submission-form?id=14691&from=1
Ontrak, Inc. (NASDAQ:OTRK)
Class Period: November 5, 2020 - February 26, 2021
Lead Plaintiff Deadline: May 3, 2021
The complaint alleges Ontrak, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Ontrak's largest customer evaluated the Company on a provider basis, valuing Ontrak's performance based on achieving the lowest cost per medical visit rather than clinical outcomes or medical cost savings; (2) as a result, Ontrak's largest customer did not find the Company's program to be effective and was reasonably likely to terminate its contract with Ontrak; (3) because this customer accounted for a significant portion of the Company's revenue, the loss of the customer would have an outsized impact on Ontrak's financial results; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Learn about your recoverable losses in OTRK: http://www.kleinstocklaw.com/pslra-1/ontrak-inc-loss-submission-form?id=14691&from=1
CytoDyn Inc. (OTCMKT:CYDY)
Class Period: March 27, 2020 - March 9, 2021
Lead Plaintiff Deadline: May 17, 2021
The CYDY lawsuit alleges CytoDyn Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: CytoDyn securities were actively traded over the counter (OTC) in the United States. While the exact number of Class members is unknown to Plaintiff at this time and can be ascertained only through appropriate discovery, Plaintiff believes that there are hundreds or thousands of members in the proposed Class. Record owners and other members of the Class may be identified from records maintained by CytoDyn or its transfer agent and/or OTC Markets and may be notified of the pendency of this action by mail, using the form of notice similar to that customarily used in securities class actions.
Learn about your recoverable losses in CYDY: http://www.kleinstocklaw.com/pslra-1/cytodyn-inc-loss-submission-form?id=14691&from=1
Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: The Klein Law Firm